Mammoth Biosciences, Agilent Partner on High-Throughput CRISPR-Based SARS-CoV-2 Diagnostic Test -
What You Should Know: – Mammoth Biosciences, the company bringing CRISPR out of the lab to help fight COVID-19 announced a partnership with lab giant Agilent to automate and scale its CRISPR-based high throughput testing system. – Building on existing partnerships with Hamilton and Merck, this deal will help deliver a workflow capable of performing more than 4,000 COVID-19 tests per day. Mammoth Biosciences, Inc. today announced a co-marketing agreement with Agilent Technologies to support the anticipated launch of a complete CRISPR-based SARS-CoV-2 diagnostic solution comprising Agilent...
Source: hitconsultant.net